Common use of Index of Other Defined Terms Clause in Contracts

Index of Other Defined Terms. In addition to the terms defined above, the following terms shall have the respective meanings given thereto in the sections indicated below: Defined Term Section “Adverse Recommendation Change” 7.03(a) “Agreement” Preamble “Assignment Agreement” Recitals “BDC Election” 5.18(b) “Board” Recitals “Change of Recommendation Notice” 7.03(c) “Chosen Courts” 12.08(a) “CLO Partners” Preamble “Closing” 4.01 “Commitment Letter” Recitals “Company” Preamble “Company Adviser” Recitals “Company Board Recommendation” 5.02(b) “Company Financial Advisor” 5.20 “Company SEC Documents” 5.07(a) “Company Securities” 5.05(b) “Company Stockholder Approvals” 7.02 “Company Stockholder Meeting” 7.02 “Company Stockholder Proposals” 7.02 “Definitive Proxy Statement” 9.02(a) “End Date” 11.01(b) “Entity” 6.07 “Expense Reimbursement” 11.03(c) “Fee-Sharing Arrangements” 5.26(e) “GSC Sub” 5.06 “Indemnified Person” 9.06 “Investment” 2.01 “Investor” Preamble “License Agreement” 2.02 “Loan Repayment” 2.03 Defined Term Section “Make-Whole Payment” 11.03(d) “Money Laundering Laws” 6.12 “No Vote Expense Reimbursement” 11.03(b) “NYSE Rules” 5.07(i) “Preliminary Proxy Statement” 9.02(a) “Proxy Statement” 5.09 “Registration Rights Agreement” 2.02 “Replacement Administration Agreement” Recitals “Replacement Advisory Agreement” Recitals “Replacement Facility” 2.02 “Replacement Lender” 2.02 “Replacement Management Agreements” Recitals “Representatives” 7.03(a) “Saratoga” Preamble “Saratoga Commitment Letter” 6.05(b) “Saratoga Directors” 2.02 “SDAT” 5.01 “Shares” 2.01 “Takeover Statute” 5.22(a) “Tax” 5.16(o) “Tax Return” 5.16(o) “Tax Sharing Agreement” 5.16(o) “Tax Authority” 5.16(o) “Transfer Restrictions” 3.03 “Termination Fee” 11.03(a) “Underlying Beneficial Owner” 6.07

Index of Other Defined Terms. In addition to the those terms defined above, the following terms terms, in their capitalized forms, shall have the respective meanings given thereto in the sections indicated below: Defined Term Section “Adverse Recommendation Change” 7.03(a) “Agreement” Preamble “Assignment AgreementCancelable ESCT Common Share” 1.3(xii) “Delaware Corporate Law” Recitals “BDC ElectionEffective Time” 5.18(b1.2 “ESCT” Preamble “ESCT Audited Financial Statements” 3.9(a) “BoardESCT Benefit Plan” 3.22(a) “ESCT Common Stock” 1.3(xii) “ESCT Common Stock Exchange Ratio” 1.3(xii) “ESCT Common Stock Purchase Warrant” 1.3(xvi) “ESCT Convertible Debenture” 1.3(xiv) “ESCT Disclosure Schedule” Art. III Intro “ESCT Financial Statements” 3.9(a) “ESCT Foreign Plans” 3.22(r) “ESCT In-Bound Licenses” 3.19(b) “ESCT Intellectual Property” 3.19(e) “ESCT Internal Financial Statements” 3.9(a) “ESCT Lease” 3.18(c) “ESCT-Leased Real Property” 3.18(a) “ESCT Material Contracts” 3.20(b) “ESCT Minor Contracts” 3.20(e) “ESCT Option Plan” 1.3(xviii) “ESCT Out-Bound Licenses” 3.19(c) “ESCT-Owned Intellectual Property” 3.19(a) “ESCT-Owned Real Property” 3.18(a) “ESCT-Owned Software” 3.19(m)(i) “ESCT Pension Plan” 3.22(b) “ESCT Permits” 3.8 “ESCT Receivables” 3.10 “ESCT Registered Intellectual Property” 3.19(f) “ESCT Replacement Option” 1.3(xviii) “ESCT Stockholders” Recitals “Change of Recommendation NoticeESCT Stock Option” 7.03(c1.3(xviii) “Chosen CourtsExchange Agent” 12.08(a2.1(a) “CLO PartnersExchange Fund” 2.1(b) “FIND” Preamble “ClosingFIND Benefit Plan” 4.01 4.21(a) “Commitment LetterFIND Common Stock” Recitals “CompanyFIND Common Stock Purchase Warrant” Preamble “Company Adviser” Recitals “Company Board Recommendation” 5.02(b1.3(xv) “Company Financial AdvisorFIND Convertible Debenture” 5.20 “Company SEC Documents” 5.07(a1.3(xiii) “Company SecuritiesFIND Disclosure Schedule” 5.05(bArt. IV Intro “FIND Foreign Plans” 4.21(r) “Company Stockholder ApprovalsFIND In-Bound Licenses” 7.02 “Company Stockholder Meeting” 7.02 “Company Stockholder Proposals” 7.02 “Definitive Proxy Statement” 9.02(a4.18(b) “End DateFIND Intellectual Property” 11.01(b4.18(e) “EntityFIND Lease” 6.07 “Expense Reimbursement” 11.03(c4.17(c) “FeeFIND-Sharing ArrangementsLeased Real Property” 5.26(e4.17(a) “GSC SubFIND Material Contracts” 5.06 “Indemnified Person” 9.06 “Investment” 2.01 “Investor” Preamble “License Agreement” 2.02 “Loan Repayment” 2.03 Defined Term Section “Make-Whole Payment” 11.03(d4.19(b) “Money Laundering LawsFIND Minor Contracts” 6.12 “No Vote Expense Reimbursement” 11.03(b4.19(e) “NYSE RulesFIND Out-Bound Licenses” 5.07(i4.18(c) “Preliminary Proxy StatementFIND-Owned Intellectual Property” 9.02(a4.18(a) “Proxy StatementFIND-Owned Real Property” 5.09 “Registration Rights Agreement” 2.02 “Replacement Administration Agreement” Recitals “Replacement Advisory Agreement” Recitals “Replacement Facility” 2.02 “Replacement Lender” 2.02 “Replacement Management Agreements” Recitals “Representatives” 7.03(a4.17(a) “SaratogaFIND-Owned Software” Preamble “Saratoga Commitment Letter” 6.05(b4.18(m)(i) “Saratoga DirectorsFIND Pension Plan” 2.02 “SDAT” 5.01 “Shares” 2.01 “Takeover Statute” 5.22(a4.21(b) “TaxFIND Permits” 5.16(o4.7 “FIND Preferred Stock” 4.4(a) “Tax ReturnFIND Receivables” 5.16(o4.9 “FIND Registered Intellectual Property” 4.18(f) “Tax Sharing AgreementFIND SEC Reports” 5.16(o4.8(a) “Tax AuthorityFIND Series MX Convertible Preferred Stock” 5.16(o) “Transfer Restrictions” 3.03 “Termination Fee” 11.03(a) “Underlying Beneficial Owner” 6.071.3(xii)

Index of Other Defined Terms. In addition Accession Acceptance 40 Advisory Board 7 Advisory Board Resignation Letter 7 Affiliate 13 Agreement 6 Arbitration Agreement 44 Ardian Entity 38 BGB 9 Business 6 Business Day 14 CCC Financial Statements 2 of Exhibit 8.9 Claim Notice 24 Clean Team Agreement 27 Clearance 11 Closing 14 Closing Actions 14 Closing Bank Repayment Amount 23 Closing Conditions 11 Closing Confirmation 15 Closing Date 14 Company 5 Company Books 35 Company’s Manager 7 Control 13 Controlling 13 Data Room 27 De Minimis Amount 30 Deductible 30 Disclosure Schedule 21 Disclosures 17 Due Diligence 22 Effective Date 9 Equity Bridge 20 Exempted Claims 30 Facilities Agreement 6 Fairly Disclosed 27 Finance Documents 6 Finance Parties 23 Finance Parties’ Bank Account 23 Financing Collateral 7,8 Fundamental Guarantees 17 Further Disclosures 26 General DR USB Stick 27 Governmental Authority 12 Group 6 Group Companies 6 Guaranteed Obligations 39 Guarantor 6 Guarantor’s Guarantees 33 Indemnified Person 35 Insurer 31 Interest 9 Key Employees 6 of Exhibit 8.9 Knowledge Bearer 21 Leakage 20 Leased Real Property 6 Liability Cap 31 Liability Exclusion 31 Long Stop Date 16 Manager Resignation Letter 7 Material Agreements 4 of Exhibit 8.9 Notified Leakage Amount 10 Parties 6 Permit 10 of Exhibit 8.9 Permitted Claims 36 Permitted Leakage 20 Pre-Effective Date Tax Period 1 of Exhibit 12 Pro Rata Share 30 Purchase Price 9 Purchaser 5 Purchaser Claim 24 Purchaser’s Guarantees 33 Purchaser’s Related Parties 35 Purchaser’s Representatives 22 Purple Data Xxxx 00 Xxxxxx XX USB Stick 27 Real Property Leases 6 Red Data Room 27 Red DR USB Stick 27 Scheduled Closing Date 14 Seller 1 5 Seller 2 5 Seller 3 5 Seller 4 5 Seller 5 5 Sellers 5 Sellers’ Bank Account 10 Sellers’ Covenants 23 Sellers’ Guarantee 17 Sellers’ Indemnification Claims 36 Sellers’ Knowledge 21 Sellers’ Representative 42 Share Capital 6 Share Transfer Instrument 8 Shareholder Loan 7 Shareholder Loan Receivable 8 Shareholder Loan Termination Agreement 9 Shareholders’ Matters 3 of Exhibit 8.9 Shareholders’ Resolution Company 8 Shareholders’ Resolution Triple C Holding GmbH 7 Shareholders’ Resolutions Group Companies 8 Sold Shares 6 Subsidiary 6 Subsidiary Equity Interests 19 Subsidies 11 of Exhibit 8.9 Substitute Purchaser as defined in Section 19(e) Tax 1 of Exhibit 12 Tax Audit 1 of Exhibit 12 Tax Authority 1 of Exhibit 12 Tax Return 1 of Exhibit 12 Tax Warranties 1 of Exhibit 12 Third Party Claim 28 Time Limitations 29 Top Customers 10 Transaction 6 Unaudited CCC Financial Statements 2 of Exhibit 8.9 Unaudited Company Trial Balances 2 of Exhibit 8.9 USB Sticks 27 VVG 29 W&I Insurance 31 Waiver 36 EXHIBIT 1-A FORM OF BRING-DOWN CERTIFICATE [see attached.] Execution Venion Exhibit l·a -Form of Bring-Down Certificate-BRING-DOWN CERTIFICATE TELUS International (Cda) Inc., 000 Xxxx Xxxxxxx Xxxxxx, Xxxxx 0, Xxxxxxxxx, Xxxxxxx Xxxxxxxx, X0X XX0, Xxxxxx (the "Purchaser") TO: RE: Sbare Purchase Agreement (the "SPA") dated as of [ •] December 2019 among Triple C Institutional Holding SA ("Seller 1"), Sunshine MEP "Beteiligungs GmbH & Co. KG ("Seller 2"), Uif Herbrechter ("Seller 3''), Xxxxxx Kloibhofer ("Seller 4") and Xxxxxxxxx Xxxxx ("Seller S'', together with Sellers 1 through 4, the "Sellers''), tbe Purchaser and TELUS Communications Inc.(''Guarantor") [G]2020 XXxX: This Bring-Down certificate (this "Certificate") is being delivered by the Sellers to the terms Purchaser pursuant to Section 7.2(a) of the SPA. Capitalized tenns used but not defined above, the following terms shall in this Certificate wiD have the respective meanings given thereto ascribed to them in the sections indicated belowSPA The undersigned Sellers, hereby confinn. to the Sellers' Knowledge that: Defined Term Notwithstanding the "as of the date hereof' quaJifiers in the third sentence of Section “8.1 of the SPA and in the lead-in sentence of Section 2 of Exhibit 12 of theSPA, theSellers'Guarantees and the Tax Warranties are true and conect on and as of the date of this Certificate as though the Sellers' Guarantee and the Tax Warranties were made on and as of the date of this Certificate (except in case of any particular Sellers' Guarantee and any Tax Warranties that is expressly stated in the wording of such Sellers' Guarantee or Tax Warranty to relate to a particular date, which shaD only be true as of such date), except to the extent that any failure of any Sellers' Guarantee or Tax Warranty to be so true and correct has not had. individually or in the aggregate, a Material Adverse Recommendation Change” 7.03(aEffect, it being understood that this Certificate shall not establish any rights of the Purchaser against the Sellers, in particular not any rights to rescind or challenge or contest or nullify the SPA and shall not extent the liability of the Sellers towards the Purchaser under or in connection with the SPA beyond what has been explicitly agreed between the Partiesin the SPA. This Certificate may be delivered in origjnal or electronic fonn, and when so delivered will be deemed to be an original. [Signature page follows] Xxx-DOCS\26746929.1 Execution Version Triple C Institutional Holding SA Signature Signature Name: Position: Name: Position: Sunshine MEP Betelligungs GmbH & Co. KG, represented by Sunshine MEP GmbH Signarure Name:Xxxxxxxxx Xxxxx Position:Managing director Xxxxxx Kloibhofer, Signature Name:Xxxxxx Kloibhofer Ulf Herbrecbter Xxxxxxxxx Xxxxx Signature Signature Name: Cfuistian Xxxxx Xxxxx:Ulf Her:xxxxxx.xx EU-POCS\26746929.1 EXHIBIT 1-B APPROVED FORECAST [redacted][Description: content of Exhibit 1-B redacted.] EXHIBIT 2.1(c) “Agreement” Preamble “Assignment Agreement” Recitals “BDC Election” 5.18(bSOLD SHARES [redacted][Description: content of Exhibit 2.1(c) “Board” Recitals “Change redacted.] EXHIBIT 2.1(d) SUBSIDIARY [redacted][Description: content of Recommendation Notice” 7.03(cExhibit 2.1(d) “Chosen Courts” 12.08(a) “CLO Partners” Preamble “Closing” 4.01 “Commitment Letter” Recitals “Company” Preamble “Company Adviser” Recitals “Company Board Recommendation” 5.02(b) “Company Financial Advisor” 5.20 “Company SEC Documents” 5.07(a) “Company Securities” 5.05(b) “Company Stockholder Approvals” 7.02 “Company Stockholder Meeting” 7.02 “Company Stockholder Proposals” 7.02 “Definitive Proxy Statement” 9.02(a) “End Date” 11.01(b) “Entity” 6.07 “Expense Reimbursement” 11.03(c) “Fee-Sharing Arrangements” 5.26(e) “GSC Sub” 5.06 “Indemnified Person” 9.06 “Investment” 2.01 “Investor” Preamble “License Agreement” 2.02 “Loan Repayment” 2.03 Defined Term Section “Make-Whole Payment” 11.03(d) “Money Laundering Laws” 6.12 “No Vote Expense Reimbursement” 11.03(b) “NYSE Rules” 5.07(i) “Preliminary Proxy Statement” 9.02(a) “Proxy Statement” 5.09 “Registration Rights Agreement” 2.02 “Replacement Administration Agreement” Recitals “Replacement Advisory Agreement” Recitals “Replacement Facility” 2.02 “Replacement Lender” 2.02 “Replacement Management Agreements” Recitals “Representatives” 7.03(a) “Saratoga” Preamble “Saratoga Commitment Letter” 6.05(b) “Saratoga Directors” 2.02 “SDAT” 5.01 “Shares” 2.01 “Takeover Statute” 5.22(a) “Tax” 5.16(o) “Tax Return” 5.16(o) “Tax Sharing Agreement” 5.16(o) “Tax Authority” 5.16(o) “Transfer Restrictions” 3.03 “Termination Fee” 11.03(a) “Underlying Beneficial Owner” 6.07redacted.]

Index of Other Defined Terms. In addition to the terms defined above, Each of the following terms shall have is defined on the respective meanings given thereto in the sections indicated belowpage set forth opposite such term: Defined Term 338 Increased Tax Liability 54 Accounting Principles 17 Acquired Subsidiary IP 31 Acquired Subsidiary Licensed IP 31 Active Employees 49 Adjustment Escrow Amount 20 Agreement 1 Allocation 15 Antitrust Laws 48 assessments 30 Assumed Agreements 2 Assumed Employment Agreements 2 Assumed Liabilities 6 Assumed Real Property Leases 2 Assumption Approval 13 Avoidance Actions 5 Base Amount 16 Buyer 1 Buyer Adjustment Amount 20 Buyer Benefit Plans 51 Buyer Default Termination 21 Canadian Customer Data 62 Closing 23 Closing Date 23 Closing Date Schedule 17 Closing Payment 16 Closing Payroll Periods 50 COBRA 51 Contract Designation Liabilities 14 Cure Payments 13 CV Cap 6 Deposit 21 Determination Date 54 Dispute Notice 18 Divested Assets 6 DOC 47 Documentary Materials 2 Employment Commencement Date 49 Environmental Laws 35 Equity Interests 2 Escrow Account 21 Escrow Agent 21 Escrow Agreement 21 Estimated Indebtedness 17 Estimated Net Working Capital Amount 16 Exchange Act 27 Excluded Assets 4 Excluded Employees 50 Excluded Liabilities 8 FCPA 37 Final Calculations 19 FTC 47 Hazardous Materials 35 HSR Act 47 Inactive Employees 49 Indebtedness Schedule 17 IRS 28 Motions 56 Necessary Consents 13 Offeree 49 Owned Real Property 2 Parties 1 Party 1 PBGC 29 Post-Closing Credit Facility 66 Professional Services 8 Purchase Price 16 Purchased Assets 15 Real Property Leases 34 Restructuring Liabilities 68 Restructuring Transactions 68 Review Period 18 Sale Order 69 SEC 24 Section “Adverse Recommendation Change” 7.03(a338(g) “Agreement” Preamble “Assignment Agreement” Recitals “BDC Election” 5.18(b) “Board” Recitals “Change of Recommendation Notice” 7.03(c) “Chosen Courts” 12.08(a) “CLO Partners” Preamble “Closing” 4.01 “Commitment Letter” Recitals “Company” Preamble “Company Adviser” Recitals “Company Board Recommendation” 5.02(b) “Company Election 54 Securities Act 27 Seller 1 Seller Adjustment Amount 21 Seller Financial Advisor” 5.20 “Company Statements 27 Seller Properties 35 Seller SEC Documents” 5.07(a) “Company Securities” 5.05(b) “Company Stockholder Approvals” 7.02 “Company Stockholder Meeting” 7.02 “Company Stockholder Proposals” 7.02 “Definitive Proxy Statement” 9.02(a) “End Date” 11.01(b) “Entity” 6.07 “Expense Reimbursement” 11.03(c) “Fee-Sharing Arrangements” 5.26(e) “GSC Sub” 5.06 “Indemnified Person” 9.06 “Investment” 2.01 “Investor” Preamble “License Agreement” 2.02 “Loan Repayment” 2.03 Defined Term Section “Make-Whole Payment” 11.03(d) “Money Laundering Laws” 6.12 “No Vote Expense Reimbursement” 11.03(b) “NYSE Rules” 5.07(i) “Preliminary Proxy Statement” 9.02(a) “Proxy Statement” 5.09 “Registration Rights Agreement” 2.02 “Replacement Administration Agreement” Recitals “Replacement Advisory Agreement” Recitals “Replacement Facility” 2.02 “Replacement Lender” 2.02 “Replacement Management Agreements” Recitals “Representatives” 7.03(a) “Saratoga” Preamble “Saratoga Commitment Letter” 6.05(b) “Saratoga Directors” 2.02 “SDAT” 5.01 “Shares” 2.01 “Takeover Statute” 5.22(a) “Tax” 5.16(o) “Reports 27 Selling Entities 1 Tax Return” 5.16(o) “Tax Sharing Agreement” 5.16(o) “Tax Authority” 5.16(o) “Incentive Agreement 33 Termination Date 72 Transfer Restrictions” 3.03 “Termination Fee” 11.03(a) “Underlying Beneficial Owner” 6.07Taxes 52 Transferred Employees 49 Transferred Insurance Policies 61

Index of Other Defined Terms. In addition to the those terms defined above, the following terms shall have the respective meanings given thereto in the sections indicated below: Defined Term Section “Adverse Recommendation Change” 7.03(a) “Page ”Agreement” Preamble “Assignment Preamble, 3 ”Patriot Indemnitees” 9.2, 20 ”Closing Date” 2.6, 9 ”Patriot License to Intel” Recitals, 4 ”Closing” 2.6, 8 ”Patriot Rights Holders” Recitals, 3 ”Commercialization Agreement” Recitals, 3 ”Patriot/TPL Indemnitees” 9.3, 20 ”Consent and Release Agreement” Recitals “BDC Election4 ”Patriot” 5.18(bPreamble, 3 ”Consent and Release Consideration” 2.7(f) “Board9 ”P-Newco” Recitals “Change of Recommendation NoticeRecitals, 4 ”Escrow Account” 7.03(c) “Chosen CourtsRecitals, 3 ”Proceedings” 12.08(a) “CLO Partners” Preamble “Closing” 4.01 “Commitment Letter” Recitals “Company” Preamble “Company Adviser” Recitals “Company Board Recommendation” 5.02(b) “Company Financial Advisor” 5.20 “Company SEC Documents” 5.07(a) “Company Securities” 5.05(b) “Company Stockholder Approvals” 7.02 “Company Stockholder Meeting” 7.02 “Company Stockholder Proposals” 7.02 “Definitive Proxy Statement” 9.02(a) “End Date” 11.01(b) “Entity” 6.07 “Expense Reimbursement” 11.03(c) “Fee-Sharing Arrangements” 5.26(e) “GSC Sub” 5.06 “Indemnified Person” 9.06 “Investment” 2.01 “Investor” Preamble “License 3.7, 11 ”Escrow Agreement” 2.02 “Loan Repayment” 2.03 Defined Term Section “Make-Whole Payment” 11.03(d) “Money Laundering Laws” 6.12 “No Vote Expense Reimbursement” 11.03(b) “NYSE Rules” 5.07(i) “Preliminary Proxy Statement” 9.02(a) “Proxy Statement” 5.09 “Recitals, 3 ”Registration Rights Agreement” 2.02 “Replacement Administration Recitals, 3 ”Grant” Recitals, 4 ”Stipulated Final Judgment” Recitals, 4 ”Intel Parties” 11.13, 27 ”Termination Date” 10.1, 22 ”Intel” Recitals, 4 ”T-Newco” Recitals, 4 ”Merger Agreement” Recitals “Replacement Advisory AgreementRecitals, 4 ”TPL Indemnitees” Recitals “Replacement Facility9.1, 19 ”Xxxxx” 2.02 “Replacement LenderPreamble, 3 ”TPL” 2.02 “Replacement Management AgreementsPreamble, 3 ”MSD Patents” Recitals “RepresentativesRecitals, 3 ”Trade Secrets Litigation” 7.03(a) “Saratoga” Preamble “Saratoga Commitment Letter” 6.05(b) “Saratoga Directors” 2.02 “SDAT” 5.01 “Shares” 2.01 “Takeover Statute” 5.22(a) “Tax” 5.16(o) “Tax Return” 5.16(o) “Tax Sharing Agreement” 5.16(o) “Tax Authority” 5.16(o) “Transfer Restrictions” 3.03 “Termination Fee” 11.03(a) “Underlying Beneficial Owner” 6.07Recitals, 4

Index of Other Defined Terms. In addition to the terms defined above, Each of the following terms shall have is defined on the respective meanings given thereto in the sections indicated belowpage set forth opposite such term: Defined Acceptable Estoppel 28 Accounting Firm 31 Acquired Leased Real Property 3 Acquired Owned Real Property 3 Acquired Seller Plan 4 Acquired Subsidiaries 4 Acquired Subsidiary 4 Acquired Subsidiary Designation Date 4 Adjustment Escrow Amount 32 Agreement 1 Allocations 98 Ancillary Agreement 35 Anti-Corruption Laws 44 Bankruptcy Case 1 Bankruptcy Court 1 Break-Up Fee 96 Chosen Courts 109 Closing 27 Closing Account 20 Closing Dates 27 Closing Statement 29 Closings 27 COBRA Liabilities 74 Commitment Letters 55 Company 1 Company Inventory Amounts 21 Confidential Information 85 Contracting Parties 106 Counterparty 28 Credit Bid 1 Credit Bid Amount 1 Credit Bid Encumbrances 1 Cure Costs 10 Debt 55 Debt Financing 55 Deed 25 Deposit 23 Deposit Escrow Account 23 Designee 18 Disputed Claims Order 22 Disputed Reserved Claims Amounts 23 Distribution Centers Lease Agreement 77 Effect 122 Effective Date 1 Encumbered Assets 1 Enforceability Exceptions 35 Environmental Permits 45 Equity Commitment Letters 55 Equity Financing 55 Escrow Agent 23 Escrow Agreement 23 Estimated Closing Cash 21 130 Estimated Closing Statement 21 Estimated October EBITDA 21 Excluded Assets 7 Excluded Contracts 7 Excluded Documents 7 Excluded Liabilities 10 Express Representations 57 Filed SEC Documents 34 Final Actual Inventory Shrink Factors 32 Final Cash Payment 29 Final Closing Cash 32 Final Inventory Amounts 32 Final November Non-Operating Costs 32 Final October EBITDA 32 Financial Statements 37 Financing 55 Financing Fees 103 First Interim Distribution 22 Foreign Competition Laws 35 Fundamental Representations 88 GOB Stores 8 Indebtedness 65 India Subsidiaries 98 Initial OpCo Contract Schedule 13 Initial PropCo Contract Schedule 13 Instruction Letter 1 Intent-To-Use Trademark 5 Intercompany Liabilities 52 Interim Budget 22 Interim Period Rent Payments 68 Interim Period Rent Payments Account 69 Investors 55 Master Lease Agreement 77 Material Contracts 40 Material Suppliers 52 Milestones 61 Non-Debtor Subsidiaries 36 Non-Party Affiliates 106 Objection Notice 30 OFAC 121 OpCo Acquired Assets 2 OpCo Acquired Leased Real Property 3 OpCo Acquired Leases 24 OpCo Acquired Owned Real Property 3 OpCo Allocation 97 OpCo Assigned Contracts 13 OpCo Assignment and Assumption Agreement 24 OpCo Assignment and Assumption of Lease 24 OpCo Assumed Liabilities 8 OpCo Available Contracts 13 OpCo Closing 24 OpCo Closing Date 24 OpCo Closing Date Escrow Amount 26 OpCo Credit Bid Amount 19 OpCo Cure Costs 10 OpCo Designation Rights Period 14 OpCo Non-Assigned Contracts 13 OpCo Outside Date 92 OpCo Purchaser 1 OpCo Purchaser Adjustment Amount 32 OpCo Purchaser Plans 73 OpCo Sale 1 OpCo Special Allocation 98 OpCo Tax Return 100 OpCo Term Section “Adverse Recommendation Change” 7.03(a) “Agreement” Preamble “Loan B Credit Agreement 26 OpCo-Company Closing Date Payment 20 Parties 1 Party 1 Payoff Amount 21 Payoff Indebtedness 21 Payoff Letter 21 Plan Effective Date 2 Projections 58 PropCo 92 PropCo Acquired Assets 6 PropCo Acquired Leased Real Property 6 PropCo Acquired Leases 6 PropCo Acquired Owned Real Property 6 PropCo Agreements 68 PropCo Allocation 98 PropCo Assigned Contracts 13 PropCo Assignment Agreement” Recitals “BDC Election” 5.18(b) “Board” Recitals “Change and Assumption Agreement 27 PropCo Assignment and Assumption of Recommendation Notice” 7.03(c) “Chosen Courts” 12.08(a) “CLO Partners” Preamble “Closing” 4.01 “Commitment Letter” Recitals “Company” Preamble “Company Adviser” Recitals “Company Board Recommendation” 5.02(b) “Company Financial Advisor” 5.20 “Company SEC Documents” 5.07(a) “Company Securities” 5.05(b) “Company Stockholder Approvals” 7.02 “Company Stockholder Meeting” 7.02 “Company Stockholder Proposals” 7.02 “Definitive Proxy Statement” 9.02(a) “End Date” 11.01(b) “Entity” 6.07 “Expense Reimbursement” 11.03(c) “FeeLease 27 PropCo Assumed Liabilities 9 PropCo Available Contracts 13 PropCo Closing 27 PropCo Closing Date 27 PropCo Credit Bid Amount 20 PropCo Cure Costs 10 PropCo Designation Rights Period 15 PropCo Non-Sharing Arrangements” 5.26(e) “GSC Sub” 5.06 “Indemnified Person” 9.06 “Investment” 2.01 “Investor” Preamble “License Agreement” 2.02 “Loan Repayment” 2.03 Defined Term Section “MakeAssigned Contracts 14 PropCo Pre-Whole Payment” 11.03(d) “Money Laundering Laws” 6.12 “No Vote Expense Reimbursement” 11.03(b) “NYSE Rules” 5.07(i) “Preliminary Proxy Statement” 9.02(a) “Proxy Statement” 5.09 “Registration Rights Agreement” 2.02 “Replacement Administration Agreement” Recitals “Replacement Advisory Agreement” Recitals “Replacement Facility” 2.02 “Replacement Lender” 2.02 “Replacement Management Agreements” Recitals “Representatives” 7.03(a) “Saratoga” Preamble “Saratoga Commitment Letter” 6.05(b) “Saratoga Directors” 2.02 “SDAT” 5.01 “Shares” 2.01 “Takeover Statute” 5.22(a) “Tax” 5.16(o) “Tax Return” 5.16(o) “Tax Sharing Agreement” 5.16(o) “Tax Authority” 5.16(o) “Closing Reorganization 2 PropCo Purchaser 1 PropCo Sale 2 PropCo Subidiaries 2 PropCo Trust 2 Property Documents 38 Proposed November Non-Operating Costs 21 Proprietary Software 47 Purchaser Released Claims 112 Purchasers 1 Real Estate Plans 39 Real Estate Warranties 39 Related Parties 112 Related Party 112 RemainCo TSA 25 Remaining Escrow Funds 32 Required Amount 56 Reserved Claims 22 Reserved Claims Budget 22 Review Period 30 S/B REA/Ground Lease 28 Second Interim Distribution 23 Seller 1 Seller Released Claims 112 Sellers 1 Settlement Date 32 Specified Litigation 5 Support Obligations 79 Trade Secrets 121 Transaction 2 Transfer Restrictions” 3.03 “Termination Fee” 11.03(a) “Underlying Beneficial Owner” 6.07Offer 72 Transfer Taxes 97 Transferee Purchaser 79 Transferred Employees 72 Transferring Purchaser 79 Transition Services Agreement 25 Trustee 62 U.S. Registered Intellectual Property 45 WARN Act 74 WARN List 51 Wind-Down Operating Budget 22

Index of Other Defined Terms. In addition to the terms defined above, the following terms shall have the respective meanings given thereto in the sections indicated below: Defined Term Section “Adverse Recommendation Change” Section 7.03(a) “Adviser” Recitals “Agreement” Preamble “Assignment AgreementAmended Company Articles” Recitals Section 2.04(a) “Bankruptcy Exceptions” Section 5.02(a) “BDC Election” 5.18(bSection 5.15(b) “BoardBuyer” Recitals Preamble “Change of Recommendation NoticeBuyer Financial Advisor” 7.03(c) 6.14 “Chosen Courts” 12.08(a) “CLO Partners” Preamble “Closing” 4.01 “Commitment Letter” Recitals Section 12.08 “Company” Preamble “Company AdviserArticles” Section 2.04(a) “Company Board” Recitals “Company Board Recommendation” 5.02(bSection 5.02(a) “Company Financial AdvisorCommon Stock” 5.20 Recitals “Company Regulatory Approvals” Section 5.03 “Company SEC Documents” 5.07(aSection 5.06(b) “Company Securities” Section 5.05(b) “Company Stockholders” Recitals “Company Stockholder ApprovalsApproval” 7.02 Section 5.02(a) “Company Stockholder Meeting” 7.02 Recitals “Company Stockholder ProposalsProposal” Section 7.02 Confidential Information Section 9.08 “Definitive Proxy StatementContemplated Transactions” 9.02(aRecitals “Designated Person” Section 2.04(b) “End Direct Purchase Closing” Section 4.02 “Direct Purchase Closing Date” 11.01(bSection 4.02 “Direct Purchase Closing Notice” Section 2.02(b) “EntityDirect Purchase Period” 6.07 “Expense Reimbursement” 11.03(cSection 2.02(b) “Fee-Sharing ArrangementsDirect Stock Purchase” 5.26(eSection 2.02(a) “GSC Sub” 5.06 “Indemnified Person” 9.06 “Investment” 2.01 “Investor” Preamble “License Agreement” 2.02 “Loan Repayment” 2.03 Defined Term Section “Make-Whole Payment” 11.03(d) “Money Laundering Laws” 6.12 “No Vote Expense Reimbursement” 11.03(b) “NYSE Rules” 5.07(i) “Preliminary Proxy Statement” 9.02(a) “Proxy Statement” 5.09 “Registration Rights Agreement” 2.02 “Replacement Existing Administration Agreement” Recitals “Replacement Existing Advisory Agreement” Recitals “Replacement FacilityInitial Closing” 2.02 Section 4.01 “Replacement LenderInitial Closing Date” 2.02 Section 4.01 “Replacement Management Agreements” Recitals “Representatives” 7.03(a) “Saratoga” Preamble “Saratoga Commitment Letter” 6.05(b) “Saratoga Directors” 2.02 “SDAT” 5.01 “Shares” 2.01 “Takeover Statute” 5.22(a) “Tax” 5.16(o) “Tax Return” 5.16(o) “Tax Sharing Interest Purchase Agreement” 5.16(o) “Tax Authority” 5.16(o) “Transfer Restrictions” 3.03 “Termination Fee” 11.03(a) “Underlying Beneficial Owner” 6.07Recitals

Index of Other Defined Terms. In addition to the those terms defined above, the following terms shall have the respective meanings given thereto in the sections indicated below: Defined Term Section “Adverse Recommendation Change” 7.03(a) “Agreement” Preamble “Assignment Agreement” Recitals “BDC Election” 5.18(b) “Board” Recitals “Change of Recommendation Notice” 7.03(c) “Chosen Courts” 12.08(a) “CLO PartnersAMD” Preamble “ClosingAMD Asset Purchase Agreement” 4.01 “Commitment Letter” Recitals “Company” Preamble “Company Adviser” Recitals “Company Board Recommendation” 5.02(b4.1(b) “Company Financial AdvisorAMD Asset Sale Promissory Note” 5.20 “Company SEC Documents” 5.07(a4.1(c) “Company SecuritiesAMD Assumed Liabilities” 5.05(b2.2 “AMD Closing Date Contributed Assets” 2.1(a) “Company Stockholder ApprovalsAMD Contributed Assets” 7.02 “Company Stockholder Meeting” 7.02 “Company Stockholder Proposals” 7.02 “Definitive Proxy Statement” 9.02(a2.1(b) “End DateAMD Contributed Contracts” 11.01(b2.1(a) “EntityAMD Contributed Leased Real Property” 6.07 “Expense Reimbursement” 11.03(c5.6(a) “Fee-Sharing ArrangementsAMD Contributed Owned Real Property” 5.26(e5.6(b) “GSC SubAMD Contributed Permits” 5.06 5.9(a) “Indemnified PersonAMD Deductible” 9.06 10.8(a) “InvestmentAMD Distribution Agreement” 2.01 4.1(b) “InvestorAMD Entities” Preamble 5.1 “AMD Employment Agreements” 5.11(a) “AMD-FASL Patent Cross-License Agreement” 2.02 4.1(b) “Loan RepaymentAMD Flash Memory Business” 2.03 Recitals Defined Term Section “MakeAMD Flash Memory Business Income Statements” 5.24 “AMD Indemnitees” 10.4 “AMD Investments” Preamble “AMD Post-Whole PaymentClosing Contributed Assets” 11.03(d2.1(b) “Money Laundering Laws” 6.12 “No Vote Expense Reimbursement” 11.03(b) “NYSE Rules” 5.07(i) “Preliminary Proxy Statement” 9.02(a) “Proxy Statement” 5.09 “Registration Rights Agreement” 2.02 “Replacement Administration AgreementAMD Pre-Closing Contributed Assets” Recitals “Replacement Advisory AMD Pre-Closing Taxes” 2.4 “AMD Promissory Note” 4.1(c) “AMD Services Agreement” 4.1(b) “AMD Site” 5.15(a) “AMD Technology Services Agreement” 4.1(b) “AMD Threshold” 10.8(a) “Applicable Interest Rate” 8.9(b) “Assumed Liabilities” 2.2 “Austin Title Policy” 7.6(b) “Claimant” 10.9(a) “Closing” 4.1(a) “Closing Date” 4.1(a) “Confidentiality Agreement” 12.13(b) “Contribution Consideration” Article III “Fab 25 Deed” 4.1(b) “FASL/AMD Services Agreement 4.1(b) “FASL (Japan)” Recitals “Replacement FacilityFASL (Japan) Employee Pension Fund” 2.02 “Replacement Lender” 2.02 “Replacement Management Agreements” Recitals “Representatives” 7.03(a) “Saratoga” Preamble “Saratoga Commitment Letter” 6.05(b) “Saratoga Directors” 2.02 “SDAT” 5.01 “Shares” 2.01 “Takeover Statute” 5.22(a) “Tax” 5.16(o) “Tax Return” 5.16(o) “Tax Sharing Agreement” 5.16(o) “Tax Authority” 5.16(o) “Transfer Restrictions” 3.03 “Termination Fee” 11.03(a) “Underlying Beneficial Owner” 6.078.9(b)

Index of Other Defined Terms. In addition to the those terms defined above, the following terms shall have the respective meanings given thereto in the sections indicated below: Defined Term Section “Adverse Recommendation Change” 7.03(a) “Page ”Agreement” Preamble “Assignment Preamble, 3 ”Closing Date” 2.6, 9 ”Closing” 2.6, 8 ”Commercialization Agreement” Recitals, 3 ”Consent and Release Agreement” Recitals “BDC Election4 ”Consent and Release Consideration” 5.18(b2.7(f) “Board9 ”Escrow Account” Recitals “Change of Recommendation Notice” 7.03(c) “Chosen Courts” 12.08(a) “CLO Partners” Preamble “Closing” 4.01 “Commitment Letter” Recitals “Company” Preamble “Company Adviser” Recitals “Company Board Recommendation” 5.02(b) “Company Financial Advisor” 5.20 “Company SEC Documents” 5.07(a) “Company Securities” 5.05(b) “Company Stockholder Approvals” 7.02 “Company Stockholder Meeting” 7.02 “Company Stockholder Proposals” 7.02 “Definitive Proxy Statement” 9.02(a) “End Date” 11.01(b) “Entity” 6.07 “Expense Reimbursement” 11.03(c) “Fee-Sharing Arrangements” 5.26(e) “GSC Sub” 5.06 “Indemnified Person” 9.06 “Investment” 2.01 “Investor” Preamble “License Recitals, 3 ”Escrow Agreement” 2.02 “Loan RepaymentRecitals, 3 ”Grant” 2.03 Defined Term Section “MakeRecitals, 4 ”Intel Parties” 11.13, 27 ”Intel” Recitals, 4 ”Merger Agreement” Recitals, 4 ”Xxxxx” Preamble, 3 ”MSD Patents” Recitals, 3 ”Newco Licenses” Recitals, 4 ”Operating Agreement” Recitals, 3 ”Patriot Indemnitees” 9.2, 20 ”Patriot License to Intel” Recitals, 4 ”Patriot Rights Holders” Recitals, 3 ”Patriot/TPL Indemnitees” 9.3, 20 ”Patriot” Preamble, 3 ”P-Whole PaymentNewco” 11.03(d) “Money Laundering LawsRecitals, 4 ”Proceedings” 6.12 “No Vote Expense Reimbursement” 11.03(b) “NYSE Rules” 5.07(i) “Preliminary Proxy Statement” 9.02(a) “Proxy Statement” 5.09 “3.7, 11 ”Registration Rights Agreement” 2.02 “Replacement Administration AgreementRecitals, 3 ”Stipulated Final Judgment” Recitals “Replacement Advisory AgreementRecitals, 4 ”Termination Date” Recitals “Replacement Facility10.1, 22 ”T-Newco” 2.02 “Replacement LenderRecitals, 4 ”TPL Indemnitees” 2.02 “Replacement Management Agreements9.1, 19 ”TPL” Recitals “RepresentativesPreamble, 3 ”Trade Secrets Litigation” 7.03(a) “SaratogaRecitals, 4 ”Warrant” Preamble “Saratoga Commitment Letter” 6.05(b) “Saratoga Directors” 2.02 “SDAT” 5.01 “Shares” 2.01 “Takeover Statute” 5.22(a) “Tax” 5.16(o) “Tax Return” 5.16(o) “Tax Sharing Agreement” 5.16(o) “Tax Authority” 5.16(o) “Transfer Restrictions” 3.03 “Termination Fee” 11.03(a) “Underlying Beneficial Owner” 6.07Recitals, 3

Index of Other Defined Terms. In addition to the those terms defined above, the following terms terms, in their capitalized forms, shall have the respective meanings given thereto in the sections indicated below: Defined Term Section “Adverse Recommendation Change2009 Plan” 7.03(a7.3(b) “Affiliate Agreement” 2.2(j) “Agreement” Preamble “Assignment Amended & Restated Voting Agreement” Recitals “BDC ElectionAuthorized Stock Increase Amendment” 5.18(b7.3(b) “BoardXxxxx Option Plan” 2.1(a)(vi) “Cancelable Common Share” 2.1(a)(i) “Cancelable Company Common Stock Purchase Warrant” 2.2(a) “Cancelable Company Convertible Debenture” 2.2(a) “Cancelable Company Series A Convertible Preferred Stock Purchase Warrant” 2.2(a) “Cancelable Securities” 2.2(a) “Cancelable Series A Convertible Preferred Share” 2.1(a)(ii) “Cancelable Series A Convertible Preferred Stock” 2.1(a)(ii) “Certificate of Merger” 1.1 “Closing” 1.2 “Closing Date” 1.2 “Code” Recitals “Change of Recommendation NoticeCommon Stock Purchase Warrant Exchange Agreement” 7.03(c7.3(d)(iii)(10) “Chosen Courts” 12.08(a) “CLO Partners” Preamble “Closing” 4.01 “Commitment Letter” Recitals “Company” Preamble “Company AdviserBenefit Plan” 4.21(a) “Company Certificate of Designations Amendment” 7.3(b) “Company Common Stock” 2.1(a)(i) “Company Common Stock Purchase Warrant” 2.1(a)(iv) “Company Convertible Debenture” 2.1(a)(iii) “Company Series A Convertible Preferred Purchase Warrant” 2.1(a)(v) “Company Disclosure Schedule” Art. IV Intro “Company Foreign Plans” 4.21(r) “Company In-Bound Licenses” 4.18(b) “Company Intellectual Property” 4.18(e) “Company Lease” 4.17(c) “Company-Leased Real Property” 4.17(a) “Company Material Contracts” 4.19(b) “Company Minor Contracts” 4.19(e) “Company Out-Bound Licenses” 4.18(c) “Company-Owned Intellectual Property” 4.18(a) “Company-Owned Real Property” 4.17(a) “Company-Owned Software” 4.18(m)(i) “Company Pension Plan” 4.21(b) “Company Permits” 4.7 “Company Principal Stockholder” Preamble “Company Proxy Statement” 7.3(b) “Company Receivables” 4.9 “Company Registered Intellectual Property” 4.18(f) “Company Series A Convertible Preferred Stock” 2.1(a)(ii) “Company Series A Convertible Preferred Stock Purchase Warrant” 2.1(a)(v) “Company Special Meeting” 7.3(b) “Company Stockholder” 2.1 “Company Stock Option” 2.1(a)(vi) “Constituent Corporations” 1.1 “Convertible Debt Securities Exchange Agreement” 7.3(d)(iii)(9) “Delaware Secretary of State” 1.2 “DGCL” Recitals “Company Board RecommendationDissentable Shares” 5.02(b2.3(a) “Company Financial AdvisorDissenting Holder” 5.20 “Company SEC Documents” 5.07(a2.3(a) “Company Dissenting Shares” 2.3(a) “Effective Time” 1.2 “Exchange Agent” 2.2(a) “Exchange Fund” 2.2(a) “Exchange Ratio” 2.1(a)(i) “Indemnified Parties” 7.15(b) “Listing Date” 2.2(i)1) “Merger” 1.1 “Merger Securities” 5.05(b2.2(a) “Company Stockholder Approvals” 7.02 “Company Stockholder Meeting” 7.02 “Company Stockholder Proposals” 7.02 “Definitive Proxy Statement” 9.02(a) “End Date” 11.01(b) “Entity” 6.07 “Expense Reimbursement” 11.03(c) “Fee-Sharing Arrangements” 5.26(e) “GSC Merger Sub” 5.06 “Indemnified Person” 9.06 “Investment” 2.01 “Investor” Preamble “License AgreementMerger Sub Common Stock” 2.02 “Loan Repayment” 2.03 Defined Term Section “Make-Whole Payment” 11.03(d2.1(a)(vii) “Money Laundering LawsMerger Sub Preferred Stock” 6.12 “No Vote Expense Reimbursement” 11.03(b5.4(b) “NYSE RulesMost Recent Company Balance Sheet” 5.07(i4.8(a) “Preliminary Proxy Most Recent Company Cash Flow Statement” 9.02(a4.8(a) “Proxy Most Recent Company Financial Statements” 4.8(a) “Most Recent Company Income Statement” 5.09 4.8(a) “Registration Rights AgreementMost Recent Company Statement of Stockholders’ Equity” 2.02 4.8(a) “Replacement Administration Name Change Amendment” 7.3(b) “Original Merger Agreement” Recitals “Replacement Advisory AgreementParent” Preamble “Parent Common Stock” Recitals “Replacement FacilityParent Common Stock Purchase Warrants” 2.02 “Replacement Lender” 2.02 “Replacement Management Agreements” Recitals “Representatives” 7.03(a2.2(a) “SaratogaParent Consent Actions” Preamble “Saratoga Commitment Letter” 6.05(b7.3(b) “Saratoga DirectorsParent Convertible Debt Securities” 2.02 “SDAT” 5.01 “Shares” 2.01 “Takeover Statute” 5.22(a2.2(a) “TaxParent Disclosure Schedule” 5.16(oArt. V Intro “Parent Preferred Stock” 5.4(a) “Tax Return” 5.16(oParent Representatives 7.3(c) “Tax Sharing AgreementParent Stockholders” 5.16(o7.2 “Parent Stock-Split” 7.2 “Parent Stock-Split Amendment” 7.3(b) “Tax AuthorityParent SEC Reports” 5.16(o5.7(a) “Transfer RestrictionsParent Stockholder Holdback” 3.03 7.2 “Termination FeeParent Preexisting Stock Option” 11.03(a2.1(a)(vii) “Underlying Beneficial OwnerParent Preexisting Warrant” 6.072.1(a)(vii) “Parent Written Consent” 7.3(d)(iii)(2)

Index of Other Defined Terms. In addition to the terms defined above, Each of the following additional terms shall have the respective meanings given thereto is defined in the sections indicated belowSection set forth opposite such term, which is set forth in the schedule that begins on the following page: Defined Term Section “Adverse Recommendation Change” 7.03(aAccounting Firm 5.10(e) “Agreement” Agreement Preamble “Assignment Agreement” Appraisal Shares 1.7 Certificate of Merger 1.3 Clearday Awards 1.7 Clearday Balance Sheet 3.1(e) Clearday Board of Directors Recitals “BDC Election” 5.18(bClearday Bylaws 3.1(a) “Board” Clearday Care Preferred Stock 1.4(d) Clearday Care 1.4(d) Clearday Charter 3.1(a) Clearday Collective Bargaining Agreements 3.1(m) Clearday Common Shares Recitals “Change of Recommendation Notice” 7.03(cClearday Common Stockholders Recitals Clearday Component 5.10(c) “Chosen Courts” 12.08(aClearday Development Expenditures 4.2(e) “CLO Partners” Clearday Disclosure Letter 3.1 Clearday Employee Benefit Plans 3.1(l) Clearday Percentage 5.10(c) Clearday Permits 3.1(i) Clearday Preferred Shares Recitals Clearday Preferred Stockholders Recitals Clearday Property 3.1(o) Clearday Share Certificate 2.2(a) Clearday Stockholder Action 3.1(d) Clearday Stockholder Approval 3.1(q) Clearday Preamble “Closing” 4.01 “Commitment Letter” Recitals “Company” Preamble “Company Adviser” Recitals “Company Board Recommendation” 5.02(bClosing Clearday Component 5.10(e) “Company Financial Advisor” 5.20 “Company Closing Date 1.2 Closing Parent Component 5.10(e) Closing 1.2 Competing Transaction 5.4(c) Confidentiality Agreement 5.2(b) Convertible Right 3.1(c) Covered Parent SEC Documents” 5.07(aDisclosure 3.2 Delaware Department 1.3 DGCL 1.1(a) “Company Securities” 5.05(bEffective Time 1.3 Encumbrances 3.1(o) “Company Stockholder Approvals” 7.02 “Company Stockholder Meeting” 7.02 “Company Stockholder Proposals” 7.02 “Definitive Proxy Statement” 9.02(aEnvironmental Laws 3.1(n) “End Date” 11.01(bERISA 3.1(l) “Entity” 6.07 “Expense Reimbursement” 11.03(cExchange Act 3.1(e) “Fee-Sharing Arrangements” 5.26(e) “GSC Sub” 5.06 “Indemnified Person” 9.06 “Investment” 2.01 “Investor” Preamble “License Agreement” 2.02 “Loan Repayment” 2.03 Defined Exchange Agent 2.1 Term Section “Make-Whole Payment” 11.03(dExchange Fund 2.1 Exchange Ratio 5.10(b) “Money Laundering Laws” 6.12 “No Vote Expense Reimbursement” 11.03(bFully Diluted Basis 5.10(c) “NYSE Rules” 5.07(iGAAP 3.1(e) “Preliminary Indemnified Party 5.9(a) Joint Ventures 3.1(b) Letter of Transmittal 2.2(a) Liens 3.1(b) Merger Consideration 1.4(b) Merger Registration and Proxy Statement” 9.02(aStatement 3.2(d) “Proxy Statement” 5.09 “Registration Rights Agreement” 2.02 “Replacement Administration Agreement” Merger Recitals “Replacement Advisory Agreement” OZ LP Interests 3.1(c) OZ Partnership 3.1(c) Panel 6.1(e) Parent Balance Sheet 3.2(e) Parent Board of Directors Recitals “Replacement Facility” 2.02 “Replacement Lender” 2.02 “Replacement Management Agreements” Parent Bylaws 3.2(i) Parent Charter 3.2(i) Parent Common Stock Recitals “Representatives” 7.03(aParent Component 5.10(c) “Saratoga” Parent Disclosure Letter 3.2 Parent New Preferred Stock 1.5(b) Parent Percentage 5.10(c) Parent Permits 3.2(j) Parent Preferred Stock Recitals Parent SEC Documents 3.2(e) Parent Stockholder Approval 3.2(r) Parent Stockholder Meeting 3.2(d) Parent Preamble “Saratoga Commitment Letter” 6.05(bPermitted Expenditures 4.2(e) “Saratoga Directors” 2.02 “SDAT” 5.01 “Shares” 2.01 “Purchaser Parties Preamble Recommendation 5.1(b) SEC 3.1(e) Securities Act 3.1(e) Superior Competing Transaction 5.4(d) Takeover Statute” 5.22(aStatute 3.1(t) “Tax” 5.16(oTermination Date 7.1(b) “Tax Return” 5.16(oVWAP MarketCap 5.10(c) “Tax Sharing Agreement” 5.16(oWaiver Agreements 5.8(b) “Tax Authority” 5.16(oWarrants 1.4(b) “Transfer Restrictions” 3.03 “Termination Fee” 11.03(a) “Underlying Beneficial Owner” 6.07Wire Asset Disposition 5.14(b)

Index of Other Defined Terms. In addition to the those terms defined above, the following terms terms, in their capitalized forms, shall have the respective meanings given thereto in the sections indicated below: Defined Term Section “Adverse Recommendation Change” 7.03(a) “Agreement” Preamble “Assignment AgreementCancelable ESCT Common Share” 1.3(ix) “Closing” 1.2.1 “Closing Date” 1.2.1 “Delaware Corporate Law” Recitals “BDC ElectionDeliverable ESCT Internal Financial Statements” 5.8(a) “Dissentable ESCT Shares” 2.1.3(b) “Dissentable FIND Shares” 2.1.1(e) “Dissenting ESCT Holder” 2.1.3(b) “Dissenting FIND Holder” 2.1.1(e) “Dissenting ESCT Shares” 2.1.3(b) “Dissenting FIND Shares” 2.1.1(e) “Effective Time” 1.2.2(ii) “ESCT” Preamble “ESCT Benefit Plan” 5.21(a) “ESCT Common Stock” 1.3(ix) “ESCT Common Stock Exchange Ratio” 1.3(ix) “ESCT Common Stock Purchase Warrant” 1.3(xiii) “ESCT Convertible Debenture” 1.3(xi) “ESCT Disclosure Schedule” Art. V Intro “ESCT Financial Statements” 5.8(a) “ESCT Foreign Plans” 5.21(r) “ESCT In-Bound Licenses” 5.18(b) “BoardESCT Intellectual Property” 5.18(e) “ESCT Lease” 5.17(c) “ESCT-Leased Real Property” 5.17(a) “ESCT Material Contracts” 5.19(b) “ESCT Minor Contracts” 5.19(e) “ESCT Option Plan” 1.3(xv) “ESCT Out-Bound Licenses” 5.18(c) “ESCT-Owned Intellectual Property” 5.18(a) “ESCT-Owned Real Property” 5.17(a) “ESCT-Owned Software” 5.18(m)(i) “ESCT Pension Plan” 5.21(b) “ESCT Permits” 5.7 “ESCT Receivables” 5.9 “ESCT Registered Intellectual Property” 5.18(f) “ESCT Replacement Option” 1.3(xv) “ESCT Representatives” 2.3(a) “ESCT Stockholders” Recitals “Change of Recommendation NoticeESCT Stock Option” 7.03(c1.3(xv) “Chosen CourtsExchange Agent” 12.08(a3.1(a) “CLO PartnersExchange Fund” 3.1(b) “FIND” Preamble “ClosingFIND 14C Merger Information Statement ” 4.01 2.1.1(b) “Commitment LetterFIND Benefit Plan” 7.21(a) “FIND Common Stock” Recitals “CompanyFIND Common Stock Exchange Ratio” 1.3(vii) “FIND Common Stock Purchase Warrant” 1.3(xii) “FIND Convertible Debenture” 1.3(x) “FIND Disclosure Schedule” Art. VII Intro “FIND Foreign Plans” 7.21(r) “FIND Information Statement” 2.1.1(a) “FIND In-Bound Licenses” 7.18(b) “FIND Information Statement” 2.2(a) “FIND Intellectual Property” 7.18(e) “FIND Lease” 7.17(c) “FIND-Leased Real Property” 7.17(a) “FIND Material Contracts” 7.19(b) “FIND Minor Contracts” 7.19(e) “FIND Out-Bound Licenses” 7.18(c) “FIND-Owned Intellectual Property” 7.18(a) “FIND-Owned Real Property” 7.17(a) “FIND-Owned Software” 7.18(m)(i) “FIND Pension Plan” 7.21(b) “FIND Permits” 7.7 “FIND Preferred Stock” 7.4(a) “FIND Principal Stockholders” Preamble “Company AdviserFIND Receivables” 7.9 “FIND Registered Intellectual Property” 7.18(f) “FIND Representatives” 2.3(a) “FIND Required Stockholder Authorizations” 2.1.1(a) “FIND SEC Reports” 7.8(a) “FIND Stockholder Consent” 2.1.1(b) “FIND Stockholders” Recitals “Company Board RecommendationFIND Stock Option” 5.02(b1.3(xiv) “Company Financial AdvisorFIND Voting Agreement” 5.20 “Company SEC Documents” 5.07(a2.1.1(e) “Company Florida Corporate Law” Recitals “Merger” 1.1(a) “Merger Certificate” 1.1(a) “Surviving Corporation” 1.1(a) “Merger” 1.1(b) “Merger Securities” 5.05(b1.3(xv) “Company Stockholder Approvals” 7.02 “Company Stockholder Meeting” 7.02 “Company Stockholder Proposals” 7.02 “Definitive Proxy Statement” 9.02(a) “End Date” 11.01(b) “Entity” 6.07 “Expense Reimbursement” 11.03(c) “FeeMerger-Sharing Arrangements” 5.26(e) “GSC Sub” 5.06 “Indemnified Person” 9.06 “Investment” 2.01 “Investor” Preamble “License AgreementMerger-Sub Common Stock” 2.02 “Loan Repayment” 2.03 Defined Term Section “Make-Whole Payment” 11.03(d1.3(viii) “Money Laundering LawsMerger-Sub Preferred Stock” 6.12 “No Vote Expense Reimbursement” 11.03(b) “NYSE Rules” 5.07(i) “Preliminary Proxy Statement” 9.02(a) “Proxy Statement” 5.09 “Registration Rights Agreement” 2.02 “Replacement Administration Agreement” Recitals “Replacement Advisory Agreement” Recitals “Replacement Facility” 2.02 “Replacement Lender” 2.02 “Replacement Management Agreements” Recitals “Representatives” 7.03(a) “Saratoga” Preamble “Saratoga Commitment Letter” 6.05(b) “Saratoga Directors” 2.02 “SDAT” 5.01 “Shares” 2.01 “Takeover Statute” 5.22(a) “Tax” 5.16(o) “Tax Return” 5.16(o) “Tax Sharing Agreement” 5.16(o) “Tax Authority” 5.16(o) “Transfer Restrictions” 3.03 “Termination Fee” 11.03(a) “Underlying Beneficial Owner” 6.077.4(b)